Allergy

In the study, more patients with allergies had chronic obstructive pulmonary disease (COPD), which is a known risk factor for severe disease with COVID-19.

The patient was prescribed prednisone for the rash when he was seen by emergency department physicians, and a follow up telehealth visit with the hospital’s allergy clinic was done when the patient’s symptoms were not relieved.

The study used an animal model that was conducted according to the National Advisory Committee for Laboratory Animal Research (NACLAR) guidelines.

Peanut allergies affect approximately 1.2% of the entire US population and an estimated 2.5% of the childhood population.

Patients with allergic rhinitis who received allergen immunotherapy exhibited a clinical improvement in symptoms compared with those who received standard pharmacotherapy alone.

Researchers believe the progression of allergies begins with eczema in infancy before progressing to food allergies, asthma, and hay fever later in childhood.

Although some similarities exist, a few key differences can help differentiate the symptoms.

Study finds that few documented antibiotic allergies are correct, and family physicians and pharmacists do not have sufficient knowledge on the issue.

Palforzia is an oral immunotherapy agent for the mitigation of allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanuts.

This generic drug product was determined by the FDA to be therapeutically equivalent to Adrenalin.

Two retail pharmacy case studies are presented.

Pharmacists should understand their mechanisms to facilitate high-quality, collaborative management with physicians.

Rx products features in the April 2020 issue.

Over-the-counter products featured in the April 2020 issue of Pharmacy Times.

Researchers have found that approximately 1% of children have an allergy to cow’s milk, but up to 14% of families believe their children may have the condition, pointing to official guidelines for detecting cow’s milk allergy as a possible cause for the overdiagnosis.

Aimmune’s peanut allergen power was approved by the FDA as an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanut.

The FDA has approved olopatadine hydrochloride ophthalmic 0.1% and 0.2% solution for sale as an OTC medication in the United States.

The once-daily solution will be the first once-daily eye-itch allergy-relief drop to be available without a prescription in the United States.

Treatment with this peanut immunotherapy consists of 3 phases: Initial Dose Escalation, Up-Dosing, and Maintenance.

A pharmacy-driven assessment found more than half of patients with reported penicillin allergies were able to take antibiotics from the same drug class, rather than resorting to substitutes that may have downsides.

Home remedies or medical intervention? Cause and symptoms dictate type of treatment.

The product to treat life-threatening allergies arrives amid the ongoing supply shortage.

Back-to-school season is a time of great excitement as millions of students start a new year. It also presents challenges for those who suffer from seasonal allergies.

Finding solutions to allergic conjunctivitis.